What is PharMetrics?
PharMetrics operates as a critical service provider within the pharmaceutical and healthcare ecosystem, specializing in rapid microbiological testing. The company provides essential analytical services, including sterility and endotoxin testing, ensuring that sterile preparations meet stringent USP standards. By integrating advanced diagnostic technology with a streamlined, user-friendly digital platform, PharMetrics addresses the industry's persistent need for cost-effective, high-velocity compliance verification. Their market position is defined by a commitment to technical precision and operational efficiency, serving as a vital partner for organizations that require rapid turnaround times without compromising regulatory integrity.
How much funding has PharMetrics raised?
PharMetrics has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in PharMetrics
PPP
Public-Private Partnership
What's next for PharMetrics?
With the infusion of this late-stage capital, PharMetrics is poised to accelerate its market penetration and enhance its laboratory capacity. The strategic focus will likely shift toward expanding its service portfolio and upgrading its technological stack to maintain a competitive edge in the evolving landscape of pharmaceutical quality control. As the company matures, the emphasis will remain on scaling its digital submission infrastructure to accommodate a broader client base, thereby solidifying its role as a cornerstone of the healthcare supply chain. Future growth will be driven by the increasing demand for outsourced, high-compliance testing services in an era of heightened regulatory scrutiny.
See full PharMetrics company page
